These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 4027894)

  • 1. Correlation of human bladder tumor recurrence with changes in clonogenicity of urothelial cells.
    Noronha RF; Goodall CM; Beagley KW; Stephens OB; Horne L
    Cancer; 1985 Oct; 56(7):1574-7. PubMed ID: 4027894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clonogenic growth of cells derived from bladder barbotage in patients with transitional cell carcinoma of the bladder: a preliminary report.
    Niell HB; Soloway MS; Nissenkorn I
    J Urol; 1982 Apr; 127(4):668-70. PubMed ID: 7069828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of semaphorin 3A in patients with urothelial cancer.
    Vadasz Z; Rubinstein J; Bejar J; Sheffer H; Halachmi S
    Urol Oncol; 2018 Apr; 36(4):161.e1-161.e6. PubMed ID: 29288007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
    Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
    Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
    Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
    Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparin prevention of tumor cell adherence and implantation on injured urothelial surfaces.
    See WA; Chapman PH
    J Urol; 1987 Jul; 138(1):182-6. PubMed ID: 2955131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sonography in evaluation of carcinoma of bladder.
    Dershaw DD; Scher HI
    Urology; 1987 Apr; 29(4):454-7. PubMed ID: 3551280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What is the value of urine cytology in after-care of patients with urothelial cancers?].
    Möllhoff S; Rathert P
    Urologe A; 1992 Jul; 31(4):203-5. PubMed ID: 1514198
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-invasive urine tests in diagnosis and as prognostic markers for urinary bladder carcinoma. Comparison of the BTAstat and NMP 22 tests with immunocytology using monoclonal antibodies against Lewis X and 486p3/12].
    Friedrich MG; Hellstern A; Hautmann SH; Noldus I; Huland H
    Urologe A; 2003 Apr; 42(4):523-30. PubMed ID: 12715124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluid intake and the risk of tumor recurrence in patients with superficial bladder cancer.
    Donat SM; Bayuga S; Herr HW; Berwick M
    J Urol; 2003 Nov; 170(5):1777-80. PubMed ID: 14532774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-zone histiocytes and recurrence of papillary urothelial bladder carcinoma.
    Lopez-Beltran A; Morales C; Reymundo C; Toro M
    Urol Int; 1989; 44(4):205-9. PubMed ID: 2678668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histopathological evaluation of urothelial carcinomas in transurethral resection urinary bladder tumor specimens: eight years of single center experience.
    Koyuncuer A
    Asian Pac J Cancer Prev; 2015; 16(7):2871-7. PubMed ID: 25854375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder.
    Sawczuk IS; Bagiella E; Sawczuk AT; Yun EJ
    Cancer Detect Prev; 2000; 24(4):364-8. PubMed ID: 11059567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of preoperative circulating CD8-positive lymphocytes in the urinary bladder recurrence of urothelial carcinoma.
    Lin CT; Tung CL; Tsai YS; Shen CH; Jou YC; Yu MT; Wu SF
    Urol Oncol; 2012 Sep; 30(5):680-7. PubMed ID: 21420334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acridine-orange flow cytometry of urinary bladder washings for the detection of transitional cell carcinoma of the bladder. The influence of prior local therapy.
    Têtu B; Katz RL; Kalter SP; von Eschenbach AC; Barlogie B
    Cancer; 1987 Oct; 60(8):1815-22. PubMed ID: 3652008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation.
    Trent JM; Stanisic T; Olson S
    J Urol; 1984 Jan; 131(1):146-51. PubMed ID: 6690740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary cytology and bladder biopsy in patients with bladder cancer.
    Loening S; Fallon B; Narayana A; Penick GD; Hawtrey C; Culp DA; Bonney WW
    Urology; 1978 Jun; 11(6):591-5. PubMed ID: 675925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
    Flamm J
    Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prediction of tumor recurrence and progression of superficial bladder carcinoma using an artificial neural network].
    Planz B; Deix T; Caspers HP
    Urologe A; 2007 Sep; 46(9):1138-9. PubMed ID: 17668171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.